Gates, No­vo Nordisk, Well­come foun­da­tions put $300M in glob­al health; BioN­Tech stops prostate can­cer study

Plus, news about Eye­Point, Lyra Ther­a­peu­tics and Plus Ther­a­peu­tics:

For glob­al health, $300 mil­lion: The Bill & Melin­da Gates Foun­da­tion, the No­vo Nordisk Foun­da­tion and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.